Logo image of DGX

QUEST DIAGNOSTICS INC (DGX) Stock Fundamental Analysis

USA - NYSE:DGX - US74834L1008 - Common Stock

179.595 USD
+0.09 (+0.05%)
Last: 11/10/2025, 11:00:10 AM
Fundamental Rating

5

Overall DGX gets a fundamental rating of 5 out of 10. We evaluated DGX against 100 industry peers in the Health Care Providers & Services industry. While DGX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. DGX has a decent growth rate and is not valued too expensively. Finally DGX also has an excellent dividend rating. These ratings could make DGX a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

DGX had positive earnings in the past year.
In the past year DGX had a positive cash flow from operations.
DGX had positive earnings in each of the past 5 years.
In the past 5 years DGX always reported a positive cash flow from operatings.
DGX Yearly Net Income VS EBIT VS OCF VS FCFDGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

DGX has a better Return On Assets (5.95%) than 84.00% of its industry peers.
DGX's Return On Equity of 13.27% is fine compared to the rest of the industry. DGX outperforms 79.00% of its industry peers.
DGX has a Return On Invested Capital of 8.79%. This is in the better half of the industry: DGX outperforms 76.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DGX is in line with the industry average of 9.39%.
The 3 year average ROIC (8.77%) for DGX is below the current ROIC(8.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.95%
ROE 13.27%
ROIC 8.79%
ROA(3y)6.25%
ROA(5y)8.71%
ROE(3y)14.08%
ROE(5y)18.83%
ROIC(3y)8.77%
ROIC(5y)10.97%
DGX Yearly ROA, ROE, ROICDGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

DGX has a better Profit Margin (8.88%) than 91.00% of its industry peers.
DGX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 14.71%, DGX belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
DGX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 33.47%, DGX is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
DGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.71%
PM (TTM) 8.88%
GM 33.47%
OM growth 3Y-14.9%
OM growth 5Y-3.56%
PM growth 3Y-21.92%
PM growth 5Y-4.54%
GM growth 3Y-5.79%
GM growth 5Y-1.22%
DGX Yearly Profit, Operating, Gross MarginsDGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DGX is creating some value.
Compared to 1 year ago, DGX has about the same amount of shares outstanding.
Compared to 5 years ago, DGX has less shares outstanding
Compared to 1 year ago, DGX has a worse debt to assets ratio.
DGX Yearly Shares OutstandingDGX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
DGX Yearly Total Debt VS Total AssetsDGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

DGX has an Altman-Z score of 3.21. This indicates that DGX is financially healthy and has little risk of bankruptcy at the moment.
DGX has a better Altman-Z score (3.21) than 68.00% of its industry peers.
DGX has a debt to FCF ratio of 4.07. This is a neutral value as DGX would need 4.07 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.07, DGX is doing good in the industry, outperforming 73.00% of the companies in the same industry.
DGX has a Debt/Equity ratio of 0.71. This is a neutral value indicating DGX is somewhat dependend on debt financing.
DGX has a Debt to Equity ratio (0.71) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 4.07
Altman-Z 3.21
ROIC/WACC1.01
WACC8.72%
DGX Yearly LT Debt VS Equity VS FCFDGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

DGX has a Current Ratio of 1.13. This is a normal value and indicates that DGX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, DGX is doing worse than 65.00% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that DGX should not have too much problems paying its short term obligations.
DGX has a worse Quick ratio (1.04) than 68.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.04
DGX Yearly Current Assets VS Current LiabilitesDGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.41% over the past year.
DGX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.58% yearly.
DGX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.74%.
The Revenue has been growing slightly by 5.02% on average over the past years.
EPS 1Y (TTM)10.41%
EPS 3Y-14.1%
EPS 5Y6.58%
EPS Q2Q%13.04%
Revenue 1Y (TTM)13.74%
Revenue growth 3Y-2.91%
Revenue growth 5Y5.02%
Sales Q2Q%13.18%

3.2 Future

Based on estimates for the next years, DGX will show a small growth in Earnings Per Share. The EPS will grow by 7.50% on average per year.
Based on estimates for the next years, DGX will show a small growth in Revenue. The Revenue will grow by 4.83% on average per year.
EPS Next Y9.8%
EPS Next 2Y7.76%
EPS Next 3Y8.13%
EPS Next 5Y7.5%
Revenue Next Year11.72%
Revenue Next 2Y7.54%
Revenue Next 3Y6.29%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DGX Yearly Revenue VS EstimatesDGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
DGX Yearly EPS VS EstimatesDGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.40, the valuation of DGX can be described as rather expensive.
Based on the Price/Earnings ratio, DGX is valued a bit cheaper than 74.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of DGX to the average of the S&P500 Index (26.06), we can say DGX is valued slightly cheaper.
A Price/Forward Earnings ratio of 17.15 indicates a rather expensive valuation of DGX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DGX indicates a somewhat cheap valuation: DGX is cheaper than 67.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DGX to the average of the S&P500 Index (32.73), we can say DGX is valued slightly cheaper.
Industry RankSector Rank
PE 18.4
Fwd PE 17.15
DGX Price Earnings VS Forward Price EarningsDGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DGX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DGX is cheaper than 66.00% of the companies in the same industry.
DGX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DGX is cheaper than 77.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.42
EV/EBITDA 11.74
DGX Per share dataDGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of DGX may justify a higher PE ratio.
PEG (NY)1.88
PEG (5Y)2.8
EPS Next 2Y7.76%
EPS Next 3Y8.13%

7

5. Dividend

5.1 Amount

DGX has a Yearly Dividend Yield of 1.81%.
DGX's Dividend Yield is rather good when compared to the industry average which is at 2.55. DGX pays more dividend than 88.00% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.36, DGX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

The dividend of DGX is nicely growing with an annual growth rate of 6.92%!
DGX has paid a dividend for at least 10 years, which is a reliable track record.
DGX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.92%
Div Incr Years13
Div Non Decr Years20
DGX Yearly Dividends per shareDGX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

DGX pays out 36.03% of its income as dividend. This is a sustainable payout ratio.
DGX's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP36.03%
EPS Next 2Y7.76%
EPS Next 3Y8.13%
DGX Yearly Income VS Free CF VS DividendDGX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
DGX Dividend Payout.DGX Dividend Payout, showing the Payout Ratio.DGX Dividend Payout.PayoutRetained Earnings

QUEST DIAGNOSTICS INC

NYSE:DGX (11/10/2025, 11:00:10 AM)

179.595

+0.09 (+0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners99.12%
Inst Owner Change-0.55%
Ins Owners0.3%
Ins Owner Change-0.65%
Market Cap20.08B
Revenue(TTM)10.85B
Net Income(TTM)963.00M
Analysts75
Price Target200.6 (11.7%)
Short Float %3.55%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend2.98
Dividend Growth(5Y)6.92%
DP36.03%
Div Incr Years13
Div Non Decr Years20
Ex-Date10-03 2025-10-03 (0.8)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.87%
Min EPS beat(2)0.93%
Max EPS beat(2)2.81%
EPS beat(4)4
Avg EPS beat(4)2.75%
Min EPS beat(4)0.93%
Max EPS beat(4)5.56%
EPS beat(8)7
Avg EPS beat(8)2.61%
EPS beat(12)11
Avg EPS beat(12)2.24%
EPS beat(16)15
Avg EPS beat(16)2.88%
Revenue beat(2)2
Avg Revenue beat(2)1.1%
Min Revenue beat(2)0.33%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-0.15%
Max Revenue beat(4)1.88%
Revenue beat(8)6
Avg Revenue beat(8)0.83%
Revenue beat(12)10
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)1.59%
PT rev (1m)4.81%
PT rev (3m)5.18%
EPS NQ rev (1m)-2.35%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)0.6%
EPS NY rev (3m)1.13%
Revenue NQ rev (1m)1.24%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)1.11%
Revenue NY rev (3m)1.34%
Valuation
Industry RankSector Rank
PE 18.4
Fwd PE 17.15
P/S 1.85
P/FCF 14.42
P/OCF 10.65
P/B 2.77
P/tB N/A
EV/EBITDA 11.74
EPS(TTM)9.76
EY5.43%
EPS(NY)10.47
Fwd EY5.83%
FCF(TTM)12.46
FCFY6.94%
OCF(TTM)16.86
OCFY9.39%
SpS97.03
BVpS64.91
TBVpS-29.56
PEG (NY)1.88
PEG (5Y)2.8
Graham Number119.39
Profitability
Industry RankSector Rank
ROA 5.95%
ROE 13.27%
ROCE 11.35%
ROIC 8.79%
ROICexc 9.06%
ROICexgc 40.27%
OM 14.71%
PM (TTM) 8.88%
GM 33.47%
FCFM 12.84%
ROA(3y)6.25%
ROA(5y)8.71%
ROE(3y)14.08%
ROE(5y)18.83%
ROIC(3y)8.77%
ROIC(5y)10.97%
ROICexc(3y)9.13%
ROICexc(5y)11.7%
ROICexgc(3y)38.8%
ROICexgc(5y)46.51%
ROCE(3y)11.44%
ROCE(5y)14.33%
ROICexgc growth 3Y-18.68%
ROICexgc growth 5Y-6.38%
ROICexc growth 3Y-22.78%
ROICexc growth 5Y-5.24%
OM growth 3Y-14.9%
OM growth 5Y-3.56%
PM growth 3Y-21.92%
PM growth 5Y-4.54%
GM growth 3Y-5.79%
GM growth 5Y-1.22%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 4.07
Debt/EBITDA 2.4
Cap/Depr 87.86%
Cap/Sales 4.53%
Interest Coverage 6.09
Cash Conversion 87.43%
Profit Quality 144.65%
Current Ratio 1.13
Quick Ratio 1.04
Altman-Z 3.21
F-Score8
WACC8.72%
ROIC/WACC1.01
Cap/Depr(3y)90.53%
Cap/Depr(5y)97.23%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.19%
Profit Quality(3y)115.37%
Profit Quality(5y)109.91%
High Growth Momentum
Growth
EPS 1Y (TTM)10.41%
EPS 3Y-14.1%
EPS 5Y6.58%
EPS Q2Q%13.04%
EPS Next Y9.8%
EPS Next 2Y7.76%
EPS Next 3Y8.13%
EPS Next 5Y7.5%
Revenue 1Y (TTM)13.74%
Revenue growth 3Y-2.91%
Revenue growth 5Y5.02%
Sales Q2Q%13.18%
Revenue Next Year11.72%
Revenue Next 2Y7.54%
Revenue Next 3Y6.29%
Revenue Next 5Y4.83%
EBIT growth 1Y21%
EBIT growth 3Y-17.38%
EBIT growth 5Y1.28%
EBIT Next Year44.72%
EBIT Next 3Y16.78%
EBIT Next 5YN/A
FCF growth 1Y133.73%
FCF growth 3Y-20.8%
FCF growth 5Y1.52%
OCF growth 1Y74.7%
OCF growth 3Y-15.78%
OCF growth 5Y1.42%

QUEST DIAGNOSTICS INC / DGX FAQ

Can you provide the ChartMill fundamental rating for QUEST DIAGNOSTICS INC?

ChartMill assigns a fundamental rating of 5 / 10 to DGX.


What is the valuation status for DGX stock?

ChartMill assigns a valuation rating of 4 / 10 to QUEST DIAGNOSTICS INC (DGX). This can be considered as Fairly Valued.


Can you provide the profitability details for QUEST DIAGNOSTICS INC?

QUEST DIAGNOSTICS INC (DGX) has a profitability rating of 7 / 10.


What is the expected EPS growth for QUEST DIAGNOSTICS INC (DGX) stock?

The Earnings per Share (EPS) of QUEST DIAGNOSTICS INC (DGX) is expected to grow by 9.8% in the next year.


How sustainable is the dividend of QUEST DIAGNOSTICS INC (DGX) stock?

The dividend rating of QUEST DIAGNOSTICS INC (DGX) is 7 / 10 and the dividend payout ratio is 36.03%.